Skip to Main Content

Paper Details

Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma.
J Clin Oncol
98
2018
3p, AXL, BAP1, Chromosome 3p, Clear, Clear Cell Renal Cell Carcinoma, Clear cell renal cell carcinoma, Cul2, HIF, HIF1/2, PBRM1, SETD2, VCB, VHL, VHL-mutated hereditary ccRCC, axitinib, cMET, cabozantinib, ccRCC, chromosome 3p, cytotoxic T-cell lymphocyte associated-4, fibroblast, kidney cancer, lenvatinib, mTORC1, metastatic, metastatic ccRCC, patients, pazopanib, programmed cell death-1, programmed death-ligand 1, renal cell carcinoma, sorafenib, sporadic ccRCC, sunitinib, tumor, tumor suppressor genes, vascular endothelial growth factor receptor
Author NameAffiliation
James J HsiehWashington University, National Institutes of Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center
James J HsiehWashington University, National Institutes of Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center
Christopher J RickettsWashington University, National Institutes of Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center
Thai H HoWashington University, National Institutes of Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2